GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » Pretax Margin %

OncoSil Medical (ASX:OSL) Pretax Margin % : -1,461.22% (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OncoSil Medical's Pre-Tax Income for the six months ended in Dec. 2024 was A$-6.71 Mil. OncoSil Medical's Revenue for the six months ended in Dec. 2024 was A$0.46 Mil. Therefore, OncoSil Medical's pretax margin for the quarter that ended in Dec. 2024 was -1,461.22%.

The historical rank and industry rank for OncoSil Medical's Pretax Margin % or its related term are showing as below:

ASX:OSL' s Pretax Margin % Range Over the Past 10 Years
Min: -4898.59   Med: -3853.03   Max: -1471.28
Current: -1471.28


ASX:OSL's Pretax Margin % is ranked worse than
94.51% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: 0.57 vs ASX:OSL: -1471.28

OncoSil Medical Pretax Margin % Historical Data

The historical data trend for OncoSil Medical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSil Medical Pretax Margin % Chart

OncoSil Medical Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -4,898.59 -4,623.71 -3,082.34 -2,393.62

OncoSil Medical Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,616.67 -3,768.87 -6,837.50 -1,482.05 -1,461.22

Competitive Comparison of OncoSil Medical's Pretax Margin %

For the Medical Devices subindustry, OncoSil Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoSil Medical's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OncoSil Medical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OncoSil Medical's Pretax Margin % falls into.


;
;

OncoSil Medical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OncoSil Medical's Pretax Margin for the fiscal year that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=-12.375/0.517
=-2,393.62 %

OncoSil Medical's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-6.707/0.459
=-1,461.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoSil Medical  (ASX:OSL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


OncoSil Medical Pretax Margin % Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoSil Medical Business Description

Traded in Other Exchanges
N/A
Address
7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines